Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

IL-15 Protein (AA 49-162)

IL15 Origine: Humain Hôte: Escherichia coli (E. coli) Recombinant >95 % as determined by SDS-PAGE. Active
N° du produit ABIN6386427
  • Antigène Voir toutes IL-15 (IL15) Protéines
    IL-15 (IL15) (Interleukin 15 (IL15))
    Type de proteíne
    Recombinant
    Activité biologique
    Active
    Attributs du protein
    AA 49-162
    Origine
    • 22
    • 8
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain
    Source
    • 35
    • 10
    • 10
    • 2
    • 2
    Escherichia coli (E. coli)
    Séquence
    AA 49-162
    Pureté
    >95 % as determined by SDS-PAGE.
    niveau d'endotoxine
    Less than 0.1 EU per μg by the LAL method.
    Top Product
    Discover our top product IL15 Protéine
  • Restrictions
    For Research Use only
  • Format
    Lyophilized
    Buffer
    PBS, pH 7.4
    Conseil sur la manipulation
    Please avoid repeated freeze-thaw cycles.
    Stock
    -20 °C
  • Antigène
    IL-15 (IL15) (Interleukin 15 (IL15))
    Autre désignation
    IL-15 (IL15 Produits)
    Synonymes
    IL15 Protein, AI503618 Protein, IL-15 Protein, interleukin 15 Protein, IL15 Protein, Il15 Protein
    Sujet
    Interleukin 15 is also known as IL15, IL-15, and is a cytokine with structural similarity to IL-2. Like IL-2, IL-15 binds to and signals through the IL-2/IL-15 beta chain (CD122) and the common gamma chain (gamma-C, CD132). IL-15 is secreted by mononuclear phagocytes (and some other cells) following infection by virus(es). This cytokine induces cell proliferation of natural killer cells, cells of the innate immune system whose principal role is to kill virally infected cells. Interleukin 15 (IL-15) regulates T and natural killer (NK) cell activation and proliferation. Survival signals that maintain memory T cells in the absence of antigen are provided by IL-15. This cytokine is also implicated in NK cell development. In rodent lymphocytes, IL-15 prevents apoptosis by inducing an apoptosis inhibitor, BCL2L1/BCL-x(L). IL-15 has been shown to enhance the anti-tumor immunity of CD8+ T cells in pre-clinical models. A phase I clinical trial to evaluate the safety, dosing, and anti-tumor efficacy of IL-15 in patients with metastatic melanoma and renal cell carcinoma (kidney cancer) has begun to enroll patients at the National Institutes of Health.
    Poids moléculaire
    12.8 kDa
    Pathways
    Signalistation JAK/STAT, Glycosaminoglycan Metabolic Process
Vous êtes ici:
Support technique